Considerable Differences in Burden of Disease at State Level
TUESDAY, April 10, 2018 -- There are considerable differences in the burden of disease at the state level, according to a study published in the April 10 issue of the Journal of the American Medical Association.
Ali H. Mokdad, Ph.D., from the University of Washington in Seattle, and colleagues from the U.S. Burden of Disease Collaborators describe trends in the burden of diseases, injuries, and risk factors at the state level from 1990 to 2016 using the results of the Global Burden of Disease Study.
The researchers observed a decrease in the overall death rates between 1990 and 2016 in the United States, from 745.2 to 578.0 per 100,000 persons. From 1990 to 2016, among adults aged 20 to 55 years, there was a decrease in the probability of death in 31 states and Washington, D.C. The highest and lowest life expectancies at birth were seen for Hawaii (81.3 years) and Mississippi (74.7 years) in 2016. For 1990 and 2016, the leading causes of disability-adjusted life years (DALYs) were ischemic heart disease and lung cancer; the third leading cause was low back pain and chronic obstructive pulmonary disease in 1990 and 2016, respectively. From 1990 to 2016, opioid use disorders moved up from the 11th to the seventh leading cause of DALYs.
"These data can be used to inform national health priorities for research, clinical care, and policy," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: April 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.